Physician profile

Joy Carol Burbeck

Pulmonary Disease · Collierville, TN

NPI 1578569034

$17,746.04

in general payments reported to CMS, 2019-2025

52 companies · $2,218 in 2025

The $2,218 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,770.22
Education$251.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $4,090.73 2019-2025 Nucala, Trelegy Ellipta
Astrazeneca Pharmaceuticals LP $2,513.13 2019-2025 Airsupra, Tezspire, Breztri
Boehringer Ingelheim Pharmaceuticals, INC. $1,354.88 2019-2025 Spiriva Respimat, Ofev, Stiolto Respimat
Actelion Pharmaceuticals US, INC. $1,118.41 2019-2025 Uptravi, Opsumit, Opsynvi
Genzyme Corporation $1,047.06 2019-2024
United Therapeutics Corporation $977.14 2019-2023 Tyvaso
Mallinckrodt Hospital Products INC. $895.18 2020-2025 Acthar
Merck Sharp & Dohme LLC $632.93 2019-2025 Winrevair, Belsomra
Genentech USA, INC. $596.72 2019-2021
Insmed, INC. $587.73 2019-2025 Arikayce, Brinsupri
Electromed, INC. $581.05 2024-2025 Smartvest
Amgen INC. $287.50 2022-2025 Tezspire
Sunovion Pharmaceuticals INC. $206.25 2019-2020
Philips North America LLC $200.33 2019-2025 Vest Therapy Und, (Ak6) Vest Therapy
Portola Pharmaceuticals, LLC $168.81 2019-2020
Show all 52 companies
CompanyGeneral paymentsYearsTop products
Grifols USA, LLC $165.67 2019
Pfizer INC. $150.37 2019-2025
Verona Pharma, INC. $149.05 2025 Ohtuvayre
Mallinckrodt Enterprises LLC $147.02 2019
Novartis Pharmaceuticals Corporation $147.01 2019-2021
La Jolla Pharmaceutical Company $125.46 2019-2021
Ani Pharmaceuticals, INC. $118.05 2023-2025 Purified Cortrophin Gel
Alexion Pharmaceuticals, INC. $114.73 2019-2021
Inogen, INC. $105.76 2022-2024 Inogen At Home Stationary Concentrator
Takeda Pharmaceuticals U.S.A., INC. $95.19 2020-2023 Glassia
Abbott Laboratories $95.12 2022-2023 Freestyle Libre 3, Freestyle Libre 2
Abbvie INC. $94.93 2021-2023 Ubrelvy
Regeneron Healthcare Solutions, INC. $91.79 2019-2024 Dupixent
Novo Nordisk INC $87.25 2022-2025 Ozempic, Rybelsus
Mylan Specialty L.P. $86.89 2019-2022
Mayne Pharma Commercial LLC $76.47 2019
Bayer Healthcare Pharmaceuticals INC. $74.45 2019-2023
Pulmonx Corporation $69.38 2019-2023 Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter
Harmony Biosciences LLC $63.20 2020-2021
Jazz Pharmaceuticals INC. $49.78 2019-2021
Exact Sciences Corporation $49.14 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Boston Scientific Corporation $35.61 2024 Wavewriter Alpha Prime 16
Teva Pharmaceuticals USA, INC. $31.87 2021
Allergan, INC. $30.66 2020
Sumitomo Pharma America, INC. $27.44 2024 Gemtesa
Paratek Pharmaceuticals, INC. $26.25 2019
Inspire Medical Systems, INC. $23.31 2024 Inspire
Advanced Respiratory, INC $19.22 2020
Biohaven Pharmaceutical Holding Company LTD. $18.27 2022
Csl Behring $17.52 2019
Tetraphase Pharmaceuticals, INC. $16.71 2019
Shire North American Group INC $16.55 2019
Uswm, LLC $15.00 2021
Applied Medical Technology INC $14.11 2019
Lilly USA, LLC $13.55 2022
Astellas Pharma US INC $13.45 2021
Melinta Therapeutics, LLC $11.96 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joy Carol Burbeck

$17,746.04

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $2,218 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/161821/joy-carol-burbeck

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.